SCHEMBL23677239

SCHEMBL23677239

O=Cc1cccc(S(=O)(=O)NC2CCCCC2)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.59
LMNA P02545 3/20 0.59
KMT2A Q03164 2/20 0.59
KDM4E B2RXH2 3/20 0.56
SMN1; SMN2 Q16637 2/20 0.56
RECQL P46063 1/20 0.56
HTT P42858 4/20 0.53
HPGD P15428 3/20 0.53
TSHR P16473 2/20 0.53
MAPK1 P28482 2/20 0.53
NPSR1 Q6W5P4 2/20 0.53
CYP3A4 P08684 1/20 0.51
BRD4 O60885 2/20 0.51
GAA P10253 2/20 0.49
PDE4A P27815 1/20 0.49
PDE4B Q07343 1/20 0.49
PDE4C Q08493 1/20 0.49
PDE4D Q08499 1/20 0.49
TDP1 Q9NUW8 1/20 0.48
TP53 P04637 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15651735 0.92 ALDH1A1 (0.56) ALDH1A1LMNAKMT2AKDM4ESMN1; SMN2
SCHEMBL15652482 0.81 KDR (0.46) ALDH1A1LMNAKMT2AKDM4ESMN1; SMN2
SCHEMBL3387965 0.80 ALDH1A1 (0.50) ALDH1A1LMNAKMT2AKDM4ESMN1; SMN2
SCHEMBL3387961 0.80 ALDH1A1 (0.50) ALDH1A1LMNAKMT2AKDM4ESMN1; SMN2
SCHEMBL738542 0.79 HTT (0.67) ALDH1A1LMNAKMT2AKDM4ESMN1; SMN2
SCHEMBL8015470 0.79 ALDH1A1 (0.67) ALDH1A1LMNAKMT2AKDM4ESMN1; SMN2
SCHEMBL21292733 0.78 SMN1; SMN2 (0.72) ALDH1A1LMNAKMT2AKDM4ESMN1; SMN2
SCHEMBL812698 0.77 SMN1; SMN2 (0.78) ALDH1A1LMNAKMT2AKDM4ESMN1; SMN2
SCHEMBL8396710 0.77 SMN1; SMN2 (0.78) ALDH1A1LMNAKMT2AKDM4ESMN1; SMN2
SCHEMBL11707518 0.77 SMN1; SMN2 (0.78) ALDH1A1LMNAKMT2AKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2890375-B1 SULFAMOYL-ARYLAMIDES AND THE USE THEREOF AS MEDICAMENTS FOR THE TREATMENT OF HEPATITIS B JANSSEN SCIENCES IRELAND UNLIMITED CO (IE) 2021-07-28 EP disclosed